Novel Imaging Techniques May Eliminate Need for Renal Mass Biopsy for Locally-advanced RCC

November 6, 2015

Nuclear or molecular imaging offers a promising non-invasive means of determining renal tumor histology for the purpose pretreatment risk stratification, according to a presentation at the 14th International Kidney Cancer Symposium.

Because the cT1 renal mass is a diverse clinical entity that includes a variety of benign and malignant tumor histologies, patients presenting with cT1 renal mass should ideally be managed with a risk-stratified approach.

Read the full article.